Quality control of benserazide-levodopa and carbidopa-levodopa tablets by capillary zone electrophoresis

Electrophoresis

Volumn 21, Issue 12, 2000, Pages 2432-2437

  Fanali, Salvatore ^a   Pucci, Vincenzo ^b   Sabbioni, Cesare ^b   Raggi, Maria Augusta ^b  

^a CNR   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Benserazide; Capillary zone electrophoresis; Carbidopa; Levodopa; Quality control

Indexed keywords

CAPILLARY ELECTROPHORESIS; CARBOXYLATION; DRUG PRODUCTS; ELECTROLYTES; FUSED SILICA; DISEASES;

BACKGROUND ELECTROLYTES; BENSERAZIDE; BORATE BUFFER; BUFFER PH; CAPILLARY-ZONE ELECTROPHORESIS; CARBIDOPA; LEVODOPA; PARKINSON'S DISEASE; PHARMACEUTICAL FORMULATION; PHOSPHATE BUFFERS; QUALITY;

QUALITY CONTROL;

BENSERAZIDE PLUS LEVODOPA; BORIC ACID; BUFFER; CARBIDOPA PLUS LEVODOPA; PHOSPHATE; SILICON DIOXIDE;

ACCURACY; ANALYTIC METHOD; ARTICLE; CALIBRATION; CAPILLARY ZONE ELECTROPHORESIS; DRUG ANALYSIS; DRUG INDICATION; DRUG QUALITY; DRUG STRUCTURE; PARKINSON DISEASE; PH; QUALITY CONTROL; REPRODUCIBILITY; SPECTROPHOTOMETRY; TABLET;

EID: 0033943784     PISSN: 01730835     EISSN: None     Source Type: Journal    
DOI: 10.1002/1522-2683(20000701)21:12<2432::AID-ELPS2432>3.0.CO;2-E     Document Type: Article

References (25)

1. Wasielewski, P. G., Burns, J. M., Koller, W. C., Movement Disord. 1998, 13, 90-100.
2. Oertel, W. H., Quinn, N. P., Bailliere Clin. Neur. 1997, 6, 89-108.
3. Gentil, M., Tournier, C. L., Perrin, S., Pollak, P., Prog. Neuropsychoph. 1998, 22, 1261-1274.
4. Gjessing, L. R., Borud, O., Scand. S. Clin. Lab. Invest. 1965, 17, 80-85.
5. O'Gorman, L. P., Borud, O., Khan, I. A., Gjessing, L. R., Clin. Chim. Acta 1970, 29, 111-119.
6. th edition, McGraw-Hill, New York 1996, pp. 506-513.
7. Ludin, H. P., Schweiz. Med. Wschr. 1999, 129, 741-747.
8. Wasielewski, P. G., Koller, W. C., J. Neurol. 1998, 245, 28-30.
9. Manyam, B. V., Hare, T. A., Robbs, R., Cubberley, V. B., Clin. Neuropharmacol. 1999, 22, 33-39.
10. Dingemans, J., Kleinbloesem, C. H., Crevoisier, C., Lankhaar, G., Gasser, U. E., Eur. Neurol. 1998, 39, 119-124.
11. Wu, G., Furlanut, M., Pharmacol. Res. 1999, 39, 203-210.
12. Dethy, S., Laute, M. A., Vanblercom, N., Damhaut, P., Goldman, S., Hilderbrand, J., Clin. Chem. 1997, 43, 740-744.
13. O'Connel, M. T., Tison, F., Quinn, N. P., Patsalos, P. N., Brit. J. Clin. Pharmacol. 1996, 42, 765-769.
14. Tolokan, A., Klebovich, I., Baloghemes, K., Horvai, G., J. Chromatogr. B 1997, 698, 201-207.
15. Dolezalova, M., Tkaczykova, M., J. Pharm. Biomed. Anal. 1999, 19, 555-567.
16. Dolezalova, M., Tkaczykova, M., Chirality 1999, 11, 394-403.
17. Vincent, J. B., Vigh, G., J. Chromatogr. A 1998, 817, 105-111.
18. Nagaraja, P., Murthy, K. C. S., Rangappa, K. s., Gowda, N. M. M., Talanta 1998, 46, 39-44.
19. Helaleh, M. I. H., Abunameh, E. S. M., Chemia Analityczna 1998, 43, 225-230.
20. Badawy, S. S., Issa, Y. M., Tageldin, A. S., Electroanalysis 1996, 8, 1060-1064.
21. Fatibello, O., Vieira, I. D., Analyst 1997, 122, 345-350.
22. Deyl, Z., Tagliaro, F., Miksik, I., J. Chromatogr. B 1994, 656, 3-27.
23. Wâtzig, H., Degenhardt, M., Kunkel, A., Electrophoresis 1998, 19, 2695-2752.
24. Gorton, J. E., Jameson, R. F., J. Chem. Soc. A 1968, 11, 2615-2618.
25. United States Pharmacopeia XXIV - National Formulary XIX, United States Pharmacopeial Convention, Rockville 2000, pp. 304-305, 964, 2000-2002.